BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11879819)

  • 1. Modulation of selected cell signaling genes in mouse liver by fumonisin B1.
    Bhandari N; Raghubir P ; Sharma
    Chem Biol Interact; 2002 Mar; 139(3):317-31. PubMed ID: 11879819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-related differences in subacute fumonisin B1 hepatotoxicity in BALB/c mice.
    Bhandari N; He Q; Sharma RP
    Toxicology; 2001 Aug; 165(2-3):195-204. PubMed ID: 11522378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fumonisin B(1)-induced alterations in cytokine expression and apoptosis signaling genes in mouse liver and kidney after an acute exposure.
    Bhandari N; Sharma RP
    Toxicology; 2002 Mar; 172(2):81-92. PubMed ID: 11882348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fumonisin B1-induced localized activation of cytokine network in mouse liver.
    Bhandari N; Brown CC; Sharma RP
    Food Chem Toxicol; 2002 Oct; 40(10):1483-91. PubMed ID: 12387313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of CD95-ligand and other apoptotic signaling factors by fumonisin B1, a hepatotoxic mycotoxin, in livers of mice lacking tumor necrosis factor alpha.
    Sharma RP; He Q; Johnson VJ; Voss KA
    Cytokine; 2003 Dec; 24(5):226-36. PubMed ID: 14596819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus-prone NZBWF1/J mice, defective in cytokine signaling, are resistant to fumonisin hepatotoxicity despite accumulation of liver sphinganine.
    Sharma RP; He Q; Riley RT
    Toxicology; 2005 Dec; 216(1):59-71. PubMed ID: 16159691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effects of fumonisin B1-producing and fumonisin B1-nonproducing Fusarium moniliforme isolates are similar: fumonisins B2 and B3 cause hepato- and nephrotoxicity in rats.
    Voss KA; Plattner RD; Riley RT; Meredith FI; Norred WP
    Mycopathologia; 1998; 141(1):45-58. PubMed ID: 9725030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased fumonisin hepatotoxicity in mice with a targeted deletion of tumor necrosis factor receptor 1.
    Sharma RP; Bhandari N; He Q; Riley RT; Voss KA
    Toxicology; 2001 Feb; 159(1-2):69-79. PubMed ID: 11250056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tumor necrosis factor alpha signaling by anti-tumor necrosis factor alpha antibodies and pentoxifylline is unable to prevent fumonisin hepatotoxicity in mice.
    He Q; Sharma RP
    Toxicon; 2005 Sep; 46(4):404-13. PubMed ID: 16054185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance to fumonisin toxicity in a mouse strain lacking the P75 tumor necrosis factor receptor.
    Sharma RP; Bhandari N; Riley RT; Voss KA; Meredith FI
    Toxicology; 2000 Feb; 143(2):183-94. PubMed ID: 10755704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice lacking both TNFalpha receptors show increased constitutive expression of IFNgamma: a possible reason for lack of protection from fumonisin B1 hepatotoxicity.
    Sharma RP; He Q; Johnson VJ; Suzuki H
    Cytokine; 2006 Jun; 34(5-6):260-70. PubMed ID: 16884913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fumonisin hepatotoxicity is reduced in mice carrying the human tumour necrosis factor alpha transgene.
    Sharma RP; Bhandari N; Tsunoda M; Riley RT; Voss KA
    Arch Toxicol; 2000 Jul; 74(4-5):238-48. PubMed ID: 10959799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fumonisin B1, a mycotoxin contaminant of cereal grains, and inducer of apoptosis via the tumour necrosis factor pathway and caspase activation.
    Ciacci-Zanella JR; Jones C
    Food Chem Toxicol; 1999 Jul; 37(7):703-12. PubMed ID: 10496371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunobiological effects of fumonisin B1 in experimental subchronic mycotoxicoses in rats.
    Theumer MG; López AG; Masih DT; Chulze SN; Rubinstein HR
    Clin Diagn Lab Immunol; 2002 Jan; 9(1):149-55. PubMed ID: 11777845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme.
    Voss KA; Riley RT; Norred WP; Bacon CW; Meredith FI; Howard PC; Plattner RD; Collins TF; Hansen DK; Porter JK
    Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):259-66. PubMed ID: 11359694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subchronic toxic effects of Fusarium moniliforme and fumonisin B1 in rats and mice.
    Voss KA; Riley RT; Bacon CW; Chamberlain WJ; Norred WP
    Nat Toxins; 1996; 4(1):16-23. PubMed ID: 8680749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathology and gene expression changes in rat liver during feeding of fumonisin B1, a carcinogenic mycotoxin produced by Fusarium moniliforme.
    Lemmer ER; de la Motte Hall P; Omori N; Omori M; Shephard EG; Gelderblom WC; Cruse JP; Barnard RA; Marasas WF; Kirsch RE; Thorgeirsson SS
    Carcinogenesis; 1999 May; 20(5):817-24. PubMed ID: 10334199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fumonisin B1 hepatotoxicity in mice is attenuated by depletion of Kupffer cells by gadolinium chloride.
    He Q; Kim J; Sharma RP
    Toxicology; 2005 Feb; 207(1):137-47. PubMed ID: 15590129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fumonisin B1-induced neurodegeneration in mice after intracerebroventricular infusion is concurrent with disruption of sphingolipid metabolism and activation of proinflammatory signaling.
    Osuchowski MF; Edwards GL; Sharma RP
    Neurotoxicology; 2005 Mar; 26(2):211-21. PubMed ID: 15713342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender-dependent immunosuppression following subacute exposure to fumonisin B1.
    Johnson VJ; Sharma RP
    Int Immunopharmacol; 2001 Oct; 1(11):2023-34. PubMed ID: 11606033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.